Pharmaceutical product manufacturing and marketing in India.
Annual revenue $30,400 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Galipea

Galipea is a company. Galipea offers products and services including Syrups and Tablets.

  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Galipea Molecules Pvt. Ltd
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $30.4 K (USD)
    -71.64
    as on Mar 31, 2021
  • Net Profit
    -$36.35 K (USD)
    -16519.05
    as on Mar 31, 2021
  • EBITDA
    -$35.36 K (USD)
    -4338.38
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Galipea

Galipea offers a comprehensive portfolio of products and services, including Syrups and Tablets.

Product name locked
Category locked
Primary

Syrups are manufactured to meet healthcare needs using innovative formulations and high-quality standards.

Product name locked
Category locked
Locked

Tablets are produced with natural ingredients and WHO-GMP certified processes for effective healthcare solutions.

Funding Insights of Galipea

Premium access

Detailed funding history for Galipea

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Galipea

Investments
Premium access

Investment portfolio details for Galipea

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Galipea

Premium access

Detailed financials for Galipea

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Galipea Comparisons

Galipea Primary company
Description
Pharmaceutical product manufacturing and marketing in India.
Location
-
Founded Year
-
Annual Revenue
$30.4 K (USD)
Net Profit
-$36.35 K (USD)
EBITDA
-$35.36 K (USD)
Employees
Not available
Premium access

Peer comparison for Galipea

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Galipea

Premium access

Detailed competitors of Galipea

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Galipea

Premium access

Complete news archive for Galipea

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Galipea

Annual revenue of Galipea is $30.4K as on Mar 31, 2021.

Galipea Molecules Pvt. Ltd. was established in June 2019 and registered with the Registrar of Companies in Delhi, operating as a non-government entity limited by shares. Premium quality pharmaceutical products, including syrups, tablets, capsules, injections, ointments, and sachets, are manufactured by the company to meet WHO-GMP standards. Innovative formulations derived from rich, natural ingredients are utilized to advance healthcare solutions in Indias pharmaceutical industry, with a commitment to enhancing patient outcomes through core product development.

Galipea offers Syrups and Tablets.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available